Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(29)
Published: May 31, 2024
Abstract
Extracellular
vesicles
(EVs),
crucial
mediators
of
cell‐to‐cell
communication,
hold
significant
diagnostic
potential
due
to
their
ability
concentrate
protein
biomarkers
in
bodily
fluids.
However,
challenges
isolating
EVs
from
biological
specimens
hinder
widespread
use.
The
preferred
strategy
involves
direct
analysis,
integrating
isolation
and
analysis
solutions,
with
immunoaffinity
methods
currently
dominating.
Yet,
the
heterogeneous
nature
poses
challenges,
as
proposed
markers
may
not
be
universally
present
thought,
raising
concerns
about
biomarker
screening
reliability.
This
issue
extends
EV‐mimics,
where
conventional
lack
applicability.
Addressing
these
study
reports
on
Membrane
Sensing
Peptides
(MSP)
pan‐vesicular
affinity
ligands
for
both
non‐canonical
analogs,
streamlining
capture
phenotyping
through
Single
Molecule
Array
(SiMoA).
MSP
enable
circulating
EVs,
eliminating
need
prior
isolation.
Demonstrating
clinical
translation,
technology
detects
an
EV‐associated
epitope
signature
serum
plasma,
distinguishing
myocardial
infarction
stable
angina.
Additionally,
allow
tetraspanin‐lacking
Red
Blood
Cell‐derived
overcoming
limitations
associated
antibody‐based
methods.
Overall,
work
underlines
value
complementary
tools
antibodies,
advancing
EV
diagnostics
beyond,
marking
first‐ever
peptide‐based
application
SiMoA
technology.
Trends in Cell Biology,
Journal Year:
2023,
Volume and Issue:
33(8), P. 667 - 681
Published: Feb. 1, 2023
The
study
of
extracellular
vesicles
(EVs)
and
nanoparticles
(NPs)
is
rapidly
expanding
because
recent
discoveries
have
revealed
a
much
greater
complexity
diversity
than
was
appreciated
only
few
years
ago.
New
types
EVs
NPs
recently
been
described.
Proteins
nucleic
acids
previously
thought
to
be
packaged
in
exosomes
appear
more
enriched
different
two
identified
amembranous
NPs,
exomeres
supermeres.
Thus,
our
understanding
the
cell
biology
intercellular
communication
facilitated
by
release
state
flux.
In
this
review,
we
describe
highlight
advances,
present
major
outstanding
questions.
Molecular Therapy,
Journal Year:
2023,
Volume and Issue:
31(5), P. 1231 - 1250
Published: Feb. 20, 2023
Extracellular
vesicles
(EVs)
are
gaining
increasing
attention
for
diagnostic
and
therapeutic
applications
in
various
diseases.
These
natural
nanoparticles
benefit
from
favorable
safety
profiles
unique
biodistribution
capabilities,
rendering
them
attractive
drug-delivery
modalities
over
synthetic
analogs.
However,
the
widespread
use
of
EVs
is
limited
by
technological
shortcomings
biological
knowledge
gaps
that
fail
to
unravel
their
heterogeneity.
An
in-depth
understanding
biogenesis
crucial
unlocking
full
potential.
Here,
we
explore
how
about
EV
can
be
exploited
bioengineering
load
protein
or
nucleic
acid
cargos
into
onto
EVs.
We
summarize
more
than
75
articles
discuss
findings
on
formation
composition
exosomes
microvesicles,
revealing
multiple
pathways
may
stimulation
and/or
cargo
dependent.
Our
analysis
further
identifies
key
regulators
loading
this
integrated
develop
engineered
biotherapeutics.
Journal of Extracellular Vesicles,
Journal Year:
2022,
Volume and Issue:
11(1)
Published: Jan. 1, 2022
Abstract
It
is
clear
from
Part
I
of
this
series
that
extracellular
vesicles
(EVs)
play
a
critical
role
in
maintaining
the
homeostasis
most,
if
not
all,
normal
physiological
systems.
However,
majority
our
knowledge
about
EV
signalling
has
come
studying
them
disease.
Indeed,
EVs
have
consistently
been
associated
with
propagating
disease
pathophysiology.
The
analysis
biofluids,
obtained
clinic,
an
essential
work
to
improve
understanding
their
interfere
for
therapeutic
gain,
more
fundamental
mechanisms
by
which
they
contribute
pathogenic
processes
required.
Only
discovering
how
populations
different
biofluids
change—size,
number,
and
physicochemical
composition—in
clinical
samples,
may
we
then
begin
unravel
functional
roles
translational
models
vitro
vivo,
can
feedback
clinic.
In
II
review
series,
pathology
will
be
discussed,
focus
on
vivo
evidence
potential
used
as
both
biomarkers
points
intervention.
Journal of Extracellular Biology,
Journal Year:
2022,
Volume and Issue:
1(3)
Published: March 1, 2022
Abstract
When
released
into
biological
fluids
like
blood
or
saliva,
brain
extracellular
vesicles
(EVs)
might
provide
a
window
otherwise
inaccessible
tissue,
contributing
useful
biomarkers
of
neurodegenerative
and
other
central
nervous
system
(CNS)
diseases.
To
enrich
for
EVs
in
the
periphery,
however,
cell‐specific
EV
surface
markers
are
needed.
The
protein
that
has
been
used
most
frequently
to
obtain
putative
neuronal
origin
is
transmembrane
L1
cell
adhesion
molecule
(L1CAM/CD171).
In
this
systematic
review,
we
examine
existing
literature
on
L1CAM
EVs,
including
investigations
both
disease
cancer
through
lens
minimal
information
studies
(MISEV),
specifically
domains
nomenclature
usage,
sources,
separation
characterization.
Although
numerous
have
reported
L1CAM‐associated
biomarker
signatures
correlate
with
disease,
interpretation
these
results
complicated
since
expression
not
restricted
neurons
also
upregulated
during
progression.
A
recent
study
suggested
epitopes
present
biofluids
mostly
entirely
as
cleaved,
soluble
protein.
Our
findings
practices
trends
L1CAM‐mediated
separation,
enrichment,
characterization
yield
insights
may
assist
interpreting
results,
evaluating
rigor,
suggesting
avenues
further
exploration.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(11), P. 4879 - 4903
Published: Jan. 1, 2022
In
recent
decades,
extracellular
vesicles
(EVs),
as
bioactive
cell-secreted
nanoparticles
which
are
involved
in
various
physiological
and
pathological
processes
including
cell
proliferation,
immune
regulation,
angiogenesis
tissue
repair,
have
emerged
one
of
the
most
attractive
nanotherapeutics
for
regenerative
medicine.
Herein
we
provide
a
systematic
review
latest
progress
EVs
applications.
Firstly,
will
briefly
introduce
biogenesis,
function
isolation
technology
EVs.
Then,
underlying
therapeutic
mechanisms
native
unmodified
engineering
strategies
modified
entities
be
discussed.
Subsequently,
main
focus
placed
on
repair
regeneration
applications
organs
brain,
heart,
bone
cartilage,
liver
kidney,
well
skin.
More
importantly,
current
clinical
trials
medicine
also
highlighted.
Finally,
future
challenges
insightful
perspectives
currently
developed
EV-based
biomedicine
short,
opened
new
horizons
biologists,
chemists,
nanoscientists,
pharmacists,
clinicians,
making
possible
powerful
tools
therapies
Journal of Extracellular Vesicles,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: Jan. 1, 2024
Abstract
Blood
is
the
most
commonly
used
body
fluid
for
obtaining
and
studying
extracellular
vesicles
(EVs).
While
blood
a
standard
choice
clinical
analysis,
using
as
source
of
EVs
introduces
multiple
layers
complexity.
At
Extracellular
Vesicle
Workshop
organized
by
International
Society
Vesicles
in
Helsinki
(2022),
it
became
evident
that
beginner
researchers
lack
trustworthy
information
on
how
to
initiate
their
research
avoid
common
pitfalls.
This
educational
guide
explains
composition
frequently
terminology
blood,
provides
guidelines
collection,
preparation
plasma
serum.
It
also
basic
principles
isolating
detecting
while
considering
blood‐related
factors.
The
goal
this
assist
beginners
offering
concise
evidence‐based
introduction
current
knowledge
available
resources
study
EVs.
Molecular Aspects of Medicine,
Journal Year:
2022,
Volume and Issue:
91, P. 101155 - 101155
Published: Nov. 28, 2022
Extracellular
vesicles
(EVs)
are
released
from
all
cells
in
the
body,
forming
an
important
intercellular
communication
network
that
contributes
to
health
and
disease.
The
contents
of
EVs
cell
source-specific,
inducing
distinct
signaling
responses
recipient
cells.
specificity
their
accumulation
fluid
spaces
accessible
for
liquid
biopsies
make
them
highly
attractive
as
potential
biomarkers
therapies
duality
favorable
(therapeutic)
or
unfavorable
(pathological)
messengers
is
context
dependent
remains
be
fully
determined
homeostasis
various
disease
states.
This
review
describes
use
biomarkers,
drug
delivery
vehicles,
regenerative
therapeutics,
highlighting
examples
involving
viral
infections,
cancer,
neurological
diseases.
There
growing
interest
provide
personalized
therapy
based
on
individual
patient
characteristics.
Increasing
evidence
suggests
EV
therapeutic
approaches
ideal
medicine
due
diversity
multifunctionality
EVs.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(15), P. 6455 - 6508
Published: Jan. 1, 2022
Small
extracellular
vesicles
(sEVs)
have
been
proposed
as
a
possible
solution
to
the
current
lack
of
therapeutic
interventions
for
endogenous
skin
regeneration.
We
conducted
systematic
review
available
evidence
assess
sEV
efficacy
and
safety
in
wound
healing
regeneration
animal
models.
68
studies
were
identified
Web
Science,
Scopus,
PubMed
that
satisfied
set
prespecified
inclusion
criteria.
critically
analyzed
quality
our
criteria,
with
an
emphasis
on
methodology,
reporting,
adherence
relevant
guidelines
(including
MISEV2018
ISCT
criteria).
Overall,
meta-analysis
indicated
promoted
diabetic
non-diabetic
models
influenced
various
facets
process
regardless
cell
source,
production
protocol
disease
model.
The
EV
isolation
methods,
dosing
regimen,
size
varied
among
studies.
Modification
sEVs
was
achieved
mainly
by
manipulating
source
cells
via
preconditioning,
nanoparticle
loading,
genetic
manipulation,
biomaterial
incorporation
enhance
potential.
Evaluation
potential
adverse
effects
received
only
minimal
attention,
although
none
reported
harmful
events.
Risk
bias
assessed
SYRCLE's
ROB
tool
uncertain
most
due
insufficient
limited.
In
summary,
therapy
has
enormous
However,
reproducibility
comprehensive
evaluation
are
challenged
general
transparency
reporting
guidelines.
Methodological
rigor,
standardization,
risk
analysis
at
all
stages
research
needed
promote
translation
clinical
practice.